Literature DB >> 10384374

Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment.

C Depetris-Boldini1, R Galetto, M P Videla, R de Kremer Dodelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10384374     DOI： 10.1023/a:1005597029615

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Simultaneous determination of hydroxymethylbilane synthase and uroporphyrinogen III synthase in erythrocytes by high-performance liquid chromatography.

Authors:  D J Wright; C K Lim
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

2.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  S Lindstedt; E Holme; E A Lock; O Hjalmarson; B Strandvik
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

3.  The nephropathy of type I tyrosinemia after liver transplantation.

Authors:  J Laine; M K Salo; L Krogerus; J Kärkkäinen; O Wahlroos; C Holmberg
Journal:  Pediatr Res       Date:  1995-05       Impact factor: 3.756
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.